| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1670 | 2019 |
| Infections Caused by Scedosporium spp KJ Cortez, E Roilides, F Quiroz-Telles, J Meletiadis, C Antachopoulos, ... Clinical microbiology reviews 21 (1), 157-197, 2008 | 835 | 2008 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 777 | 2014 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 505 | 2014 |
| Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in … J Meletiadis, S Pournaras, E Roilides, TJ Walsh Antimicrobial agents and chemotherapy 54 (2), 602-609, 2010 | 410 | 2010 |
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ... Emerging infectious diseases 21 (6), 1041, 2015 | 401 | 2015 |
| In vitro susceptibilities of zygomycetes to conventional and new antifungals E Dannaoui, J Meletiadis, JW Mouton, JFGM Meis, PE Verweij Journal of Antimicrobial Chemotherapy 51 (1), 45-52, 2003 | 369 | 2003 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 351 | 2014 |
| Comparison of NCCLS and 3-(4, 5-dimethyl-2-thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development … J Meletiadis, JFGM Meis, JW Mouton, JP Donnelly, PE Verweij Journal of Clinical Microbiology 38 (8), 2949-2954, 2000 | 301 | 2000 |
| In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates J Meletiadis, JW Mouton, JFGM Meis, PE Verweij Antimicrobial Agents and Chemotherapy 47 (1), 106-117, 2003 | 299 | 2003 |
| Analysis of growth characteristics of filamentous fungi in different nutrient media J Meletiadis, JFGM Meis, JW Mouton, PE Verweij Journal of Clinical microbiology 39 (2), 478-484, 2001 | 290 | 2001 |
| Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values MC Arendrup, A Prakash, J Meletiadis, C Sharma, A Chowdhary Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00485-17, 2017 | 277 | 2017 |
| In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates J Meletiadis, JFGM Meis, JW Mouton, JL Rodriquez-Tudela, JP Donnelly, ... Antimicrobial agents and chemotherapy 46 (1), 62-68, 2002 | 276 | 2002 |
| EUCAST definitive document E MC Arendrup, J Meletiadis, JW Mouton, K Lagrou, P Hamal, J Guinea, ... Def 7 (2), 1-21, 2017 | 238 | 2017 |
| Aspergillus fumigatus and aspergillosis: from basics to clinics A Arastehfar, A Carvalho, J Houbraken, L Lombardi, R Garcia-Rubio, ... Studies in mycology 100 (1), 100115-100115, 2021 | 220 | 2021 |
| Colorimetric Assay for Antifungal Susceptibility Testing ofAspergillus Species J Meletiadis, JW Mouton, JFGM Meis, BA Bouman, JP Donnelly, ... Journal of clinical microbiology 39 (9), 3402-3408, 2001 | 202 | 2001 |
| Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis T Stergiopoulou, J Meletiadis, E Roilides, DE Kleiner, R Schaufele, ... American journal of clinical pathology 127 (3), 349-355, 2007 | 164 | 2007 |
| How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) MC Arendrup, N Friberg, M Mares, G Kahlmeter, J Meletiadis, J Guinea, ... Clinical Microbiology and Infection 26 (11), 1464-1472, 2020 | 157 | 2020 |
| Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM SCA Chen, J Perfect, AL Colombo, OA Cornely, AH Groll, D Seidel, ... The Lancet Infectious Diseases 21 (12), e375-e386, 2021 | 155 | 2021 |
| In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms A Katragkou, M McCarthy, EL Alexander, C Antachopoulos, J Meletiadis, ... Journal of Antimicrobial Chemotherapy 70 (2), 470-478, 2015 | 135 | 2015 |